Clinical Trials Logo

Clinical Trial Summary

To evaluate the therapeutic effectiveness of voriconazole + micafungin versus voriconazole alone as primary therapy for invasive aspergillosis.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00423163
Study type Interventional
Source Astellas Pharma Inc
Contact
Status Withdrawn
Phase Phase 4
Start date February 2007